Related Experiment Video

Updated: Jul 20, 2026

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor
06:18

Chimeric Antigen Receptor T Cell Manufacturing on an Automated Cell Processor

Published on: August 18, 2023

Manufacturing and quality control of cell-based tumor vaccines: a scientific and a regulatory perspective

Thomas Hinz1, Christian J Buchholz, Ton van der Stappen

  • 1Divisions of Immunology and Medical Biotechnology, Paul-Ehrlich-Institut, Paul-Ehrlich-Strasse 51-59, 63225 Langen, Germany. hinth@pei.de

Journal of Immunotherapy (Hagerstown, Md. : 1997)
|September 15, 2006
PubMed

Insights

Cell-based tumor vaccines are crucial for cancer therapy, with ongoing clinical trials worldwide. This review covers vaccine types, regulatory guidance in the EU, and quality control methods like potency assays.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • Cell-based tumor vaccines are gaining prominence in treating malignant diseases.
  • Their development and production currently lack standardized guidance documents.
  • These vaccines can be categorized under somatic cell therapy or gene-transfer medicinal products.

Purpose of the Study:

  • To review diverse cell-based cancer vaccines utilized in clinical trials.
  • To discuss existing regulatory guidance within the European Union.
  • To outline methods for ensuring cell-based vaccine quality and standards.

Main Methods:

  • Literature review of cell-based cancer vaccine types in clinical trials.
  • Analysis of European Union regulatory documents pertaining to cell-based therapies.
  • Examination of quality control methodologies, including potency assays.

Main Results:

  • Identification of various cell-based cancer vaccine strategies currently under investigation.
  • Overview of the regulatory landscape for these products in the EU.
  • Description of established methods for quality assurance, such as potency testing.

Conclusions:

  • Standardized development and production guidelines are needed for cell-based tumor vaccines.
  • Regulatory frameworks exist in the EU, but specific guidance is limited.
  • Robust quality control measures, including potency assays, are essential for ensuring vaccine efficacy and safety.

More Related Videos

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells06:47

A GMP-Compliant Procedure for the Generation of Gene-Modified T cells

Published on: October 6, 2023

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Vaccine Production01:23

Vaccine Production

Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...